Afficher la couverture '12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation | Houssel-Debry, Pauline' en grand format
/5

0 avis

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Archive ouverte

Houssel-Debry, Pauline | Coilly, Audrey | Fougerou-Leurent, Claire | Jezequel, Caroline | Duvoux, Christophe | de Ledinghen, Victor | Radenne, Sylvie | Kamar, Nassim | Leroy, Vincent | Di Martino, Vincent | d'Alteroche, Louis | Canva, Valérie | Conti, Filomena | Dumortier, Jerome | Montialoux, Hélène | Lebray, Pascal | Botta-Fridlund, Danielle | Tran, Albert | Moreno, Christophe | Silvain, Christine | Besch, Camille | Perre, Philippe | Francoz, Claire | Abergel, Armando | Habersetzer, François | Debette-Gratien, Maryline | Cagnot, Carole | Diallo, Alpha | Chevaliez, Stéphane | Rossignol, Emilie | Veislinger, Aurelie | Duclos-Vallee, Jean-Charles | Pageaux, Georges-Philippe

Edité par CCSD ; Wiley-Blackwell -

International audience. Sofosbuvir (SOF) combined with NS5A inhibitors has demonstrated its efficacy in treating a recurrence of HCV after liver transplantation. However, the duration of treatment and the need for ribavirin (RBV) remain unclear in this population. Our aim was to determine whether liver transplant recipients could be treated with an SOF+NS5A inhibitor-based regimen without RBV for 12 weeks after liver transplantation (LT).

Consulter en ligne

Suggestions

Du même auteur

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Archive ouverte | Houssel-Debry, Pauline | CCSD

International audience. Meeting Abstract: 925

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Archive ouverte | Mouna, Lina | CCSD

International audience

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Archive ouverte | Dharancy, Sébastien | CCSD

International audience. Hepatitis C virus (HCV) infection is associated with reduced patient survival following combined liver-kidney transplantation (LKT). The aim of this study was to assess the efficacy and safet...

Chargement des enrichissements...